Singapore-based BioCell Innovation’s CAR-T process gets funding boost from ScaleReady

BioCell Innovations, a Singapore-based biotechnology startup pioneering next-generation CAR-T therapies, has been awarde...

April 17, 2025 | Thursday | News
Caring Cross and Burjeel Holdings partner to bring CAR-T therapy to MENA

In a major step toward democratising access to advanced healthcare, Burjeel Holdings, a leading super-specialty healthca...

April 11, 2025 | Friday | News
“There are over 650 cell and gene therapy clinical trials underway in APAC region”

What are the company’s major plans in store for 2025, particularly for the APAC region?  The pharmaceutical ...

March 31, 2025 | Monday | Opinion
Alcon acquires majority interest in Aurion Biotech to advance first-ever corneal cell therapy candidate

Alcon, the global leader in eye care, has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage co...

March 27, 2025 | Thursday | News
Xcellbio announces new partnership in Australia to improve potency for rapid cell therapy manufacturing

Xcell Biosciences Australia Pty Ltd, an Australian affiliate of the San Francisco-based instrumentation company focused ...

March 26, 2025 | Wednesday | News
Novotech strengthens clinical trial capabilities in South Korea

Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provider of Site ...

March 19, 2025 | Wednesday | News
ENCell signs MoU with Cell Resources Corp to pave way for market entry in Japan

ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...

March 14, 2025 | Friday | News
Astellas and Yaskawa to establish joint venture in Japan focused on cell therapy manufacturing

Japan-headquartered Astellas Pharma Inc. and Yaskawa Electric Corporation have signed a definitive agreement t...

March 6, 2025 | Thursday | News
Andelyn Biosciences Strengthens Gene Therapy Innovation with Expanded AAV Curator™ Platform

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

February 21, 2025 | Friday | News
Japan's PHC partners with CCRM in Canada to develop primary T-cell expansion culture processes

Japan-based PHC Corporation has signed a Master Collaboration Agreement with CCRM (based in Canada) to work together on ...

February 10, 2025 | Monday | News
Taiwan unveils groundbreaking advancements in AI-driven drug discovery and cancer therapy

By partnering with Kyoto University in Japan, China Medical University (CMU) and Healthcare System in Taiwan has es...

February 5, 2025 | Wednesday | News
CPC launches industry-first product for cell and gene therapy sterile processing

US-based CPC (Colder Products Company), part of Dover and a leading manufacturer of connection technologi...

January 31, 2025 | Friday | News
Solvias opens CoE for biologics and cell & gene therapy in Research Triangle Park in US

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics, has announced the opening of its cu...

January 28, 2025 | Tuesday | News
Cell and Gene Therapies: The Global Race to Cure Everything—Pioneering the Next Frontier in Medicine!

Cell and gene therapy (CGT) is at the frontier of medical innovation, promising transformative solutions for some of the...

November 19, 2024 | Tuesday | Analysis
AlloVir Ditches Immunotherapy, Teams Up with Kalaris to Take Over the $14 Billion Retinal Market

" In a surprising twist, AlloVir, best known for its immunotherapy work, has decided that eye diseases are the new goldm...

November 13, 2024 | Wednesday | Analysis
Isolere Bio by Donaldson Launches Research-Grade IsoTag™ AAV Reagent for Rapid, Non-Chromatographic Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...

October 18, 2024 | Friday | News
Caring Cross Champions Healthcare Equity: Dr. Boro Dropulić on Reshaping CAR-T Cell Therapies Through Decentralized Manufacturing

In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...

October 14, 2024 | Monday | News
Andelyn Biosciences Chosen by Hubble Therapeutics to Manufacture Gene Therapy for Rare Childhood Blindness Disorder

 Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...

October 11, 2024 | Friday | News